Czech National Bank Has $20.88 Million Holdings in Colgate-Palmolive Company $CL

Posted by Geri Gentry on Aug 8th, 2026

Czech National Bank lifted its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 3.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 227,764 shares of the company’s stock after buying an additional 8,236 shares during the quarter. Czech National Bank’s holdings in Colgate-Palmolive were worth $20,881,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. PensionDanmark Pensionsforsikringsaktieselskab lifted its stake in Colgate-Palmolive by 8.0% in the 2nd quarter. PensionDanmark Pensionsforsikringsaktieselskab now owns 280,937 shares of the company’s stock valued at $25,756,000 after purchasing an additional 20,878 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Colgate-Palmolive by 139.2% in the second quarter. Assenagon Asset Management S.A. now owns 1,701,244 shares of the company’s stock valued at $155,970,000 after buying an additional 990,065 shares during the last quarter. Apella Capital LLC boosted its stake in shares of Colgate-Palmolive by 10.8% during the 2nd quarter. Apella Capital LLC now owns 4,375 shares of the company’s stock worth $416,000 after acquiring an additional 428 shares during the period. 55 North Private Wealth LLC bought a new position in shares of Colgate-Palmolive during the 2nd quarter worth approximately $323,000. Finally, Evanson Financial LLC acquired a new position in shares of Colgate-Palmolive during the 2nd quarter worth approximately $272,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Up 0.3%

Shares of CL stock opened at $93.24 on Friday. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.30 and a current ratio of 1.03. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The stock has a 50 day simple moving average of $91.13 and a two-hundred day simple moving average of $89.74. The company has a market cap of $74.33 billion, a P/E ratio of 37.00, a PEG ratio of 4.54 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.04. The business had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. Colgate-Palmolive’s revenue was up 4.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.92 earnings per share. Research analysts forecast that Colgate-Palmolive Company will post 3.86 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 84.13%.

Wall Street Analyst Weigh In

CL has been the subject of a number of research analyst reports. UBS Group boosted their price objective on Colgate-Palmolive from $106.00 to $109.00 and gave the stock a “buy” rating in a report on Monday. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Colgate-Palmolive in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Monday. Royal Bank Of Canada boosted their target price on shares of Colgate-Palmolive from $102.00 to $104.00 and gave the stock an “outperform” rating in a research note on Monday. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Colgate-Palmolive in a research note on Friday, July 31st. Twelve equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $99.00.

View Our Latest Stock Analysis on Colgate-Palmolive

Insider Buying and Selling

In other Colgate-Palmolive news, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the transaction, the director directly owned 28,373 shares of the company’s stock, valued at $2,649,187.01. The trade was a 12.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Noel R. Wallace sold 161,021 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the sale, the chief executive officer owned 362,231 shares of the company’s stock, valued at approximately $33,296,273.52. The trade was a 30.77% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.43% of the company’s stock.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.